Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.
Ahmed S, Wedekind MF, Del Rivero J, Raygada M, Lockridge R, Glod JW, Flowers C, Thomas BJ, Bernstein DB, Kapustina OB, Jain A, Miettinen M, Raffeld M, Xi L, Tyagi M, Kim J, Aldape K, Malayeri AA, Kaplan RN, Allen T, Vivelo CA, Sandler AB, Widemann BC, Reilly KM; MyPART network. Ahmed S, et al. Among authors: raygada m. Cancer Res Commun. 2023 Dec 6;3(12):2468-2482. doi: 10.1158/2767-9764.CRC-23-0247. Cancer Res Commun. 2023. PMID: 37966258 Free PMC article.
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol.
Wedekind MF, Reilly KM, Rivero JD, Lockridge R, Allen T, Raygada M, Bernstein D, Thomas BJ, Vivelo C, Levine J, Shonkoev N, Aldape K, Glod J, Sandler AB, Widemann BC. Wedekind MF, et al. Among authors: raygada m. Pediatr Blood Cancer. 2023 Jun 21:e30495. doi: 10.1002/pbc.30495. Online ahead of print. Pediatr Blood Cancer. 2023. PMID: 37345354
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor.
John L, Smith H, Ilanchezhian M, Lockridge R, Reilly KM, Raygada M, Dombi E, Sandler A, Thomas BJ, Glod J, Miettinen M, Allen T, Sommer J, Levy J, Lozinsky S, Dix D, Bouffet E, MacDonald S, Mukherjee D, Snyderman CH, Rowan NR, Malyapa R, Park DM, Heery C, Gardner PA, Cote GM, Fuller S, Butman JA, Jackson S, Gulley JL, Widemann BC, Wedekind MF. John L, et al. Among authors: raygada m. Pediatr Blood Cancer. 2023 Jun 22:e30358. doi: 10.1002/pbc.30358. Online ahead of print. Pediatr Blood Cancer. 2023. PMID: 37347686
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.
Rogers JL, Wall T, Acquaye-Mallory AA, Boris L, Kim Y, Aldape K, Quezado MM, Butman JA, Smirniotopoulos JG, Chaudhry H, Tsien CI, Chittiboina P, Zaghloul K, Aboud O, Avgeropoulos NG, Burton EC, Cachia DM, Dixit KS, Drappatz J, Dunbar EM, Forsyth P, Komlodi-Pasztor E, Mandel J, Ozer BH, Lee EQ, Ranjan S, Lukas RV, Raygada M, Salacz ME, Smith-Cohn MA, Snyder J, Soldatos A, Theeler BJ, Widemann BC, Camphausen KA, Heiss JD, Armstrong TS, Gilbert MR, Penas-Prado M. Rogers JL, et al. Among authors: raygada m. J Neurooncol. 2024 Apr;167(2):349-359. doi: 10.1007/s11060-024-04613-6. Epub 2024 Mar 1. J Neurooncol. 2024. PMID: 38427131 Free PMC article.
Germline findings in cancer predisposing genes from a small cohort of chordoma patients.
Raygada M, John L, Liu A, Schultz J, Thomas BJ, Bernstein D, Miettinen M, Raffeld M, Xi L, Tyagi M, Aldape K, Glod J, Reilly KM, Widemann BC, Wedekind MF. Raygada M, et al. J Cancer Res Clin Oncol. 2024 May 3;150(5):227. doi: 10.1007/s00432-024-05706-5. J Cancer Res Clin Oncol. 2024. PMID: 38700789 Free PMC article.
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma Workshop.
Penas-Prado M, Theeler BJ, Cordeiro B, Dunkel IJ, Hau P, Mahajan A, Robinson GW, Willmarth N, Aboud O, Aldape K, Butman JA, Gajjar A, Kelly W, Rao G, Raygada M, Siegel C, Romo CG, Armstrong TS, Gilbert MR; NCI-CONNECT Adult Medulloblastoma Workshop. Penas-Prado M, et al. Among authors: raygada m. Neurooncol Adv. 2020 Aug 17;2(1):vdaa097. doi: 10.1093/noajnl/vdaa097. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 33005896 Free PMC article. Review.
Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in PMS2.
Merchant M, Raygada M, Pang Y, Quezado M, Raffeld M, Xi L, Kim J, Tyagi M, Abdullaev Z, Kim O, Sergi Z, Pillai T, Ozer B, Zaghloul K, Heiss JD, Armstrong TS, Gilbert MR, Aldape K, Wu J. Merchant M, et al. Among authors: raygada m. Front Oncol. 2022 Aug 2;12:954879. doi: 10.3389/fonc.2022.954879. eCollection 2022. Front Oncol. 2022. PMID: 35982947 Free PMC article.
Update on Targeted Therapy in Medullary Thyroid Cancer.
Okafor C, Hogan J, Raygada M, Thomas BJ, Akshintala S, Glod JW, Del Rivero J. Okafor C, et al. Among authors: raygada m. Front Endocrinol (Lausanne). 2021 Aug 19;12:708949. doi: 10.3389/fendo.2021.708949. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34489865 Free PMC article. Review.
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma Workshop.
Penas-Prado M, Wu J, Cahill DP, Brat DJ, Costello JF, Kluetz PG, Cairncross JG, van den Bent M, Verhaak RGW, Aboud O, Burger P, Chang SM, Cordova C, Huang RY, Rowe LS, Taphoorn MJB, Gilbert MR, Armstrong TS; NCI-CONNECT Oligodendroglioma Workshop. Penas-Prado M, et al. Neurooncol Adv. 2019 Dec 6;2(1):vdz048. doi: 10.1093/noajnl/vdz048. eCollection 2020 Jan-Dec. Neurooncol Adv. 2019. PMID: 33289010 Free PMC article. Review.
55 results